OPK - OPKO Health, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.3B
Enterprise Value 31.45B
Trailing P/E N/A
Forward P/E 1-14.07
PEG Ratio (5 yr expected) 1-0.39
Price/Sales (ttm)1.36
Price/Book (mrq)0.74
Enterprise Value/Revenue 31.51
Enterprise Value/EBITDA 6-15.41

Trading Information

Stock Price History

Beta (3Y Monthly) 2.09
52-Week Change 3-64.77%
S&P500 52-Week Change 37.12%
52 Week High 36.1600
52 Week Low 31.7300
50-Day Moving Average 32.0709
200-Day Moving Average 32.5704

Share Statistics

Avg Vol (3 month) 34.72M
Avg Vol (10 day) 33.34M
Shares Outstanding 5559.83M
Float 362.72M
% Held by Insiders 141.99%
% Held by Institutions 123.71%
Shares Short (Jun 28, 2019) 491.1M
Short Ratio (Jun 28, 2019) 419.29
Short % of Float (Jun 28, 2019) 425.11%
Short % of Shares Outstanding (Jun 28, 2019) 414.80%
Shares Short (prior month May 31, 2019) 495.67M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin -19.91%
Operating Margin (ttm)-19.87%

Management Effectiveness

Return on Assets (ttm)-4.62%
Return on Equity (ttm)-10.64%

Income Statement

Revenue (ttm)957.8M
Revenue Per Share (ttm)1.68
Quarterly Revenue Growth (yoy)-12.70%
Gross Profit (ttm)314.61M
EBITDA -93.94M
Net Income Avi to Common (ttm)-190.69M
Diluted EPS (ttm)-0.3350
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)207.25M
Total Cash Per Share (mrq)0.34
Total Debt (mrq)362.15M
Total Debt/Equity (mrq)20.55
Current Ratio (mrq)1.10
Book Value Per Share (mrq)2.86

Cash Flow Statement

Operating Cash Flow (ttm)-122.61M
Levered Free Cash Flow (ttm)-26.57M